The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge panel from that court found those laws to be unconstitutional. At the time of those decisions, AHA General Counsel Chad Golder stated, they “scream out for rehearing by the full Fourth Circuit. As the dissenting judge correctly points out, the majority rests its decision on arguments that the parties never made. It invents new theories of preemption that lack any basis in the law. It conflicts with the decisions of courts across the country. And it is wrong. We look forward to it being overturned.”  

The full court of appeals will now reconsider those decisions. Two federal courts of appeals have upheld similar laws in Louisiana and Arkansas. The AHA filed amicus briefs in support of the West Virginia and Maryland laws in both the district court and the 4th Circuit. 

Headline
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the…
Headline
The Centers for Medicare & Medicaid Services’ 340B Part D claims data repository became available Oct. 1 for voluntary data submissions. While data…
Headline
The AHA Sept. 23 submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act). The…
Headline
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the…
Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…